Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Braz. j. med. biol. res ; 45(1): 68-71, Jan. 2012. ilus, tab
Article in English | LILACS | ID: lil-610553

ABSTRACT

The objective of the present study was to determine if there is a relationship between serum levels of brain-derived neurotrophic factor (BDNF) and the number of T2/fluid-attenuated inversion recovery (T2/FLAIR) lesions in multiple sclerosis (MS). The use of magnetic resonance imaging (MRI) has revolutionized the study of MS. However, MRI has limitations and the use of other biomarkers such as BDNF may be useful for the clinical assessment and the study of the disease. Serum was obtained from 28 MS patients, 18-50 years old (median 38), 21 women, 0.5-10 years (median 5) of disease duration, EDSS 1-4 (median 1.5) and 28 healthy controls, 19-49 years old (median 33), 19 women. BDNF levels were measured by ELISA. T1, T2/FLAIR and gadolinium-enhanced lesions were measured by a trained radiologist. BDNF was reduced in MS patients (median [range] pg/mL; 1160 [352.6-2640]) compared to healthy controls (1640 [632.4-4268]; P = 0.03, Mann-Whitney test) and was negatively correlated (Spearman correlation test, r = -0.41; P = 0.02) with T2/FLAIR (11-81 lesions, median 42). We found that serum BDNF levels were inversely correlated with the number of T2/FLAIR lesions in patients with MS. BDNF may be a promising biomarker of MS.


Subject(s)
Adult , Female , Humans , Brain-Derived Neurotrophic Factor/blood , Multiple Sclerosis, Relapsing-Remitting/blood , Multiple Sclerosis, Relapsing-Remitting/pathology , Biomarkers/blood , Case-Control Studies , Gadolinium , Magnetic Resonance Imaging/methods
2.
Braz. j. med. biol. res ; 41(6): 493-499, June 2008. tab
Article in English | LILACS | ID: lil-485851

ABSTRACT

The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6 percent, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7 percent, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95 percentCI = 0.23-0.68).


Subject(s)
Adult , Aged , Female , Humans , Male , Middle Aged , Young Adult , Alleles , Arthritis, Rheumatoid/genetics , Autoantibodies/immunology , Epitopes/genetics , HLA-DR Antigens/genetics , Peptides, Cyclic/genetics , Arthritis, Rheumatoid/immunology , Brazil , Case-Control Studies , Enzyme-Linked Immunosorbent Assay , Epitopes/immunology , Genetic Predisposition to Disease , Genotype , HLA-DR Antigens/immunology , Polymerase Chain Reaction , Peptides, Cyclic/immunology , Young Adult
3.
Braz. j. med. biol. res ; 40(5): 671-677, May 2007. tab, graf
Article in English | LILACS | ID: lil-449087

ABSTRACT

The objective of the present study was to evaluate the production of cytokines, interferon-g (INF-g) and interleukin-10 (IL-10), in cultures of peripheral blood mononuclear cells (PBMC) from type 1 and type 2 diabetic patients and to correlate it with inadequate and adequate metabolic control. We studied 11 type 1 and 13 type 2 diabetic patients and 21 healthy individuals divided into two groups (N = 11 and 10) paired by sex and age with type 1 and type 2 diabetic patients. The PBMC cultures were stimulated with concanavalin-A to measure INF-g and IL-10 supernatant concentration by ELISA. For patients with inadequate metabolic control, the cultures were performed on the first day of hospitalization and again after intensive treatment to achieve adequate control. INF-g levels in the supernatants of type 1 diabetic patient cultures were higher compared to type 2 diabetic patients with adequate metabolic control (P < 0.001). Additionally, INF-g and IL-10 tended to increase the liberation of PBMC from type 1 and 2 diabetic patients with adequate metabolic control (P = 0.009 and 0.09, respectively). The increased levels of INF-g and IL-10 released from PBMC of type 1 and 2 diabetic patients with adequate metabolic control suggest that diabetic control improves the capacity of activation and maintenance of the immune response, reducing the susceptibility to infections.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Diabetes Mellitus, Type 1/immunology , /immunology , Interferon-gamma/biosynthesis , /biosynthesis , Leukocytes, Mononuclear/immunology , Body Mass Index , Case-Control Studies , Cells, Cultured , Diabetes Mellitus, Type 1/metabolism , /metabolism , Enzyme-Linked Immunosorbent Assay , Leukocytes, Mononuclear/metabolism , Macrolides
4.
Rev. Soc. Bras. Med. Trop ; 34(3): 243-247, maio-jun. 2001. tab
Article in English | LILACS | ID: lil-461980

ABSTRACT

Ureaplasma urealyticum (UU) and Mycoplasma hominis (MH) have been detected in the urine of women with systemic lupus erythematosus (SLE). We evaluated the presence of these mycoplasma in the endocervix of women presenting SLE. A total of 40 SLE patients (mean age 40.2 years), and 51 healthy women (mean age 30.9 years), were studied. Endocervical swabs were cultured in specific liquid media for MH or UU, detected by a quantitative color assay, and considered positive at >10(3) dilutions. Statistical analysis was performed using the two-tailed Fisher test. UU was detected in 52.5 % of patients and in 11.8% of controls (p= 0.000059). MH was detected in 20% of patients and 2% controls (p=0.003905). Both mycoplasmas were detected in 7.3% patients and 0% controls (p<0.000001). The results reported here corroborate the association of the mycoplasma infection and SLE. Thus, these agents may stimulate the production of autoreactive clones.


Ureaplasma urealyticum (UU) e Mycoplasma hominis (MH) têm sido detectados em urina de mulheres com lupus eritematoso sistêmico (LES). Avaliamos a presença destes mycoplasmas no endocervix de mulheres apresentando LES. Um total de 40 pacientes com LES (idade média de 40,2 anos), e 51 mulheres sadias (idade média de 30.9 anos), foram estudadas. Swabs do endocervix foram cultivados em meio líquido específico para MH e UU, detectados por teste colorimétrico quantitativo, considerando positivo diluições > 103 . Análise estatística foi feita usando teste de Fisher. UU foi detectado em 52,5% das pacientes e em 11,8% dos controles (p= 0.000059). MH foi detectado em 20% das pacientes e 2% dos controles (p=0.003905). Ambos mycoplasmas foram detectados em 7,3 % das pacientes e 0% dos controles (p<0.000001). Os resultados aqui reportados corroboram com a associação de infecção por mycoplasma e LES. Estes agentes podem estimular a produção de clones autoreativos.


Subject(s)
Adult , Female , Humans , Mycoplasma Infections/complications , Ureaplasma Infections/complications , Lupus Erythematosus, Systemic/complications , Mycoplasma hominis , Ureaplasma urealyticum , Mycoplasma Infections/epidemiology , Ureaplasma Infections/epidemiology , Lupus Erythematosus, Systemic/urine
5.
Rev. Inst. Med. Trop. Säo Paulo ; 32(4): 240-8, jul.-ago. 1990. ilus
Article in English | LILACS | ID: lil-91903

ABSTRACT

Numeros absolutos de leucocitos e linfocitos, de celulas T totais, indutoras/auxiliares, supresorras/citotoxicas e de celulas B estavam diminuidos no sangue periferico de pacientes com doenca de Chagas cronica. Como anticorpos antilinfocitarios estavam presentes em apenas uma minoria de pacientes, eles provavelmente nao sao responsaveis pelas anormalidades das subpopulacoes de linfocitos. Neutrofilos de pacientes estimulados por plasma autologo tratado por endotoxina mostravam atiividade quimiotatica diminuida que deve ser devida a um defeito celular intrinseco e nao a inibicao plasmatica. A migracao aleatoria dos neutrofilos estava normal. A reducao do corante "nitroblue tetrazolium" (NBT) por neutrofilos estimulados por endotoxina tambem estava diminuioda nos pacientes. Estes achados estendem a documentacao da imunossupressao na doenca de Chagas humana. Eles podem ser relevantes para autoimunidade e para defesa contra microorganismos e celulas tumorais, pelo menos em um subgrupo de pacientes com anormalidades mais pronunciadas


Subject(s)
Humans , Chagas Disease/immunology , Lymphocyte Subsets , Neutrophils/physiology , Chemotaxis, Leukocyte , Chronic Disease , Leukocyte Count , Nitroblue Tetrazolium , Antilymphocyte Serum/analysis
6.
Braz. j. med. biol. res ; 22(10): 1255-7, 1989. ilus
Article in English | LILACS | ID: lil-83386

ABSTRACT

A serum fraction from patients with sickle cell-betao thalassemia prepared by treatment with polyethyleneglycol showed increased amounts of C1q-precipitable immune complexes, i.e., 216 microng/dl (range, 141-266 microng/d) vs 181 microng/dl (range, 152-228 microng/dl) for controls (P<0.05), as well as increased amounts of protein. Levels of IgG, IgA, IgM, C3, C4 and factor B in the same fraction were within the normal range


Subject(s)
Adolescent , Adult , Middle Aged , Humans , Male , Female , Complement C1/analysis , Antigen-Antibody Complex/analysis , Hemoglobin, Sickle/analysis , Thalassemia
SELECTION OF CITATIONS
SEARCH DETAIL